One rung at a time: what affects clinical ladder participation?

Joyce Zehler1, Cheryl Covert, Lisa Seiler

  • 1At the University of Cincinnati Medical Center, Joyce Zehler is a clinical nurse IV, Cheryl Covert is a retired clinical nurse IV, Lisa Seiler is a clinical nurse IV, Margaret Lewis is the nursing director of Professional Practice and Nursing Quality, Joseph Perazzo is a research assistant, and Theresa A. Beery is the director of the Institute for Clinical Inquiry.

Nursing Management
|March 24, 2015
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Factors Influencing Attraction V: Social Skills01:29

Factors Influencing Attraction V: Social Skills

Social skills play a crucial role in shaping interpersonal interactions and enhancing individuals' ability to navigate various social environments successfully. These skills contribute to personal and professional success, influencing how others perceive and treat individuals. High social skills provide distinct advantages in numerous settings, including romantic relationships, politics, and legal proceedings. In courtroom settings, for instance, defendants who exhibit strong social skills are...
972
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K